Skip to content

The Impact of Comprehensive Post Hospital Management Based on DHI on Cardiac Function in Patients With HF

The Impact of Comprehensive Post Hospital Management Based on Digital Health Intervention on Cardiac Function in Patients With Heart Failure: a Prospective, Multicenter, Randomized Controlled Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06947148
Enrollment
104
Registered
2025-04-27
Start date
2025-04-01
Completion date
2026-02-15
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart Failure, Digital Health Intervention, Remote Dielectric Sensing, ReDS™, Comprehensive Health Care, 6 Min Walk Test, Randomized Controlled Trial

Brief summary

Due to the complex nature of HF patients' conditions, long-term treatment and management are required, especially post hospital management, which is of great significance for improving patients' cardiac function and quality of life. With the increasing popularity of smartphones and the continuous development of medical technology, digital health intervention (DHI) has emerged as a new medical model in the treatment of diseases. This study will establish a comprehensive post hospital management model of HF based on DHI, including cognitive behavioral therapy, digital self-monitoring and remote dielectric sensing (ReDS™) technology, etc., comprehensively strengthen the post hospital intervention and management of HF. Objective to explore the effect of comprehensive post hospital management based on DHI on cardiac function of patients with HF 6 months after discharge.

Interventions

OTHERComprehensive post hospital management based on digital health intervention(DHI)

Based on the routine HF management of standard of care (SOC), the intervention group will carry out comprehensive post hospital management based on DHI, including cognitive behavioral therapy, digital self-monitoring and ReDS™ technology, etc.

Sponsors

Harbin Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients hospitalized for HF, NYHA classification II-IV upon admission 2. The patient's residence is within the urban area of each center, and ReDS™ technology can be performed at home or at the outpatient clinic 3. No difficulty using smartphones, with basic Chinese reading and writing skills 4. Accept the terms and conditions of the study and obtain informed consent from the subjects/their families

Exclusion criteria

1. Age\<21 years old 2. Patients with height\<155 cm or\>190 cm, BMI\<22 kg/m2 or\>36 kg/m2, chest circumference\<80 cm or\>115 cm, and flail chest or rib fractures 3. History of pulmonary embolism 4. chronic renal failure(Scr \> 443umol/L) 5. History of heart transplantation or pacemaker implantation 6. Severe pulmonary hypertension 7. Suffering from end-stage chronic obstructive pulmonary disease, requiring home oxygen therapy 8. Massive pleural effusion 9. The subject is unable to complete the 6-minute walking test 10. Expected lifespan\<6 months 11. Researchers believe that participants are not suitable to participate in this trial (such as pregnancy, severe visual or hearing impairment, etc.) 12. Individuals who are unable to understand and/or comply with this research procedure (such as those who are addicted to alcohol, substance abuse, or have mental illnesses) 13. Currently participating in clinical trials of other devices or drugs 14. Researchers involved in the design and execution of this study

Design outcomes

Primary

MeasureTime frameDescription
6-minute walk testThe 6th month after dischargeImprovement in 6-minute walk test after discharge for 6 months

Secondary

MeasureTime frameDescription
Quality of life index (QLI) ratingThe 1st ,3rd and 6th months after discharge
Kansas city cardiomyopathy questionnaire (KCCQ-23) ratingThe 1st ,3rd and 6th months after discharge
NYHA classificationThe 1st ,3rd and 6th months after discharge
Left ventricular ejection fraction (LVEF)The 6th month after dischargeMeasured by echocardiography
Number of readmissions for heart failureWithin 6 months after dischargeNumber of readmissions for hospitalized patients with heart failure due to worsening heart failure after discharge
All-cause mortalityWithin 6 months after discharge
Cardiac deathWithin 6 months after dischargeAny death caused by heart disease (such as myocardial infarction, low output HF, fatal arrhythmia), death without witnesses, death from unknown causes, and all surgery related deaths, including those related to concurrent treatment, are classified as cardiac death
Composite endpoint of all-cause death or readmission due to heart failureWithin 6 months after discharge
Time to first hospitalization for heart failure from baselineWithin 6 months after discharge

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026